BHARAT IMMUNOLOGICALS Corporate Bonds and Current Financial Leverage

BHARAT IMMUNOLOGICALS financial leverage is the degree to which the firm utilises its fixed-income securities. Companies with high leverage are usually considered to be at financial risk. BHARAT IMMUNOLOGICALS financial risk is the risk to BHARAT IMMUNOLOGICALS stockholders that is caused by an increase in debt. In other words with a high degree of financial leverage come high interest payments which usually reduces Earnings Per Share (EPS). See also Trending Equities.

BHARAT IMMUNOLOGICALS Financial Leverage Rating

Not Rated
Total Macroaxis Rating
 
N/A
Average S&P Rating

BHARAT IMMUNOLOGICALS Debt to Cash Allocation

The company has accumulated zero balance in total debt with debt to equity ratio (D/E) of 3.8 implying the company greatly relies on financing operations through barrowing. BHARAT IMMUNOLOGICALS has Current Ratio of 1.75 which is within standard range for the sector.

Did you try this?

Run Analyst Recommendations Now

   

Analyst Recommendations

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

BHARAT IMMUNOLOGICALS Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Merck and Allergan Plc. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
See also Trending Equities. Please also try Market Hitters module to find equities that experience drastic asymmetry in trading patters, price, volume, or investment outlook..
Search macroaxis.com